Frontlight ResearchEarly access
Trial site
Mission Cardiovascular Research Institute
- 8running trials
- 4closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Atrial fibrillation4 trials
- Peripheral artery disease4 trials
- Stroke3 trials
- Heart failure2 trials
- Chronic kidney disease1 trial
- Coronary artery disease1 trial
- Deep vein thrombosis and pulmonary embolism1 trial
- High blood pressure1 trial
- Obesity1 trial
- Phase
- Phase 35 trials
- Phase 21 trial
- Status
- Active, not recruiting4 trials
- Completed4 trials
- Recruiting4 trials
- Lead sponsor
- Regeneron Pharmaceuticals3 trials
- Janssen Research & Development, LLC2 trials
- Novo Nordisk A/S2 trials
- Abbott Medical Devices1 trial
- M.A. Med Alliance S.A.1 trial
- and 3 more
Running trials
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Recruiting
Recruiting
Recruiting
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atrial fibrillation3 recruiting
- Stroke3 recruiting
- Deep vein thrombosis and pulmonary embolism1 recruiting
- Heart failure1 recruiting
- Obesity1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026